Fmoc-(3S,4S,5S)-4-amino-3-hydroxy-5-methylheptanoic acid is a non-proteinogenic amino acid derivative featuring a unique β-hydroxy-α-amino acid structure with three contiguous stereocenters. The presence of the fluorenylmethyloxycarbonyl (Fmoc) group at the N-terminus makes it a protected building block suitable for standard solid-phase peptide synthesis (SPPS) protocols. This compound is primarily utilized as a chiral intermediate in the synthesis of complex peptides and peptidomimetics. Its specific stereochemistry and the β-hydroxy group are crucial structural motifs that can influence the conformation, stability, and biological activity of the final peptide. It is particularly valuable in medicinal chemistry research for constructing constrained peptide analogs and exploring structure-activity relationships (SAR) in drug discovery programs targeting various diseases. The compound is supplied as a high-purity solid and requires storage under inert conditions to maintain stability. It is a specialized reagent used in advanced peptide synthesis rather than a bulk chemical or a final active pharmaceutical ingredient (API).